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Ayurvedic  sciences  helped  the  early  humans  to  overcome  chronic  dangerous  diseases.  There  are
thousands of varieties of herbs and medicinal plants used to overcome such dreadful diseases. The
genus  Barleria L.  belongs  to  family  Acanthaceae,  a  medicinally  significant  group  of  plants  having
diversified phytochemicals  used for  different pharmacological  properties.  It  has been utilized since
ancient  times  for  medicinal  purposes.  It  has  many plant  secondary  metabolites  such as terpenes,
flavonoids, lignins, alkaloids, particularly the iridoid glycosides.  The secondary metabolites extracted
from  Barleria spp.  show potential  pharmacological  activities  viz.,  anti-microbial,  anti-inflammatory,
anti-oxidant,  anti-fertility,  anti-arthritic  and  anti-ulcer  activity.  In  view  of  these,  present  review  is
focused on the phytochemistry,  pharmacology and tissue culture studies of some of the important
species of the genus Barleria L.
Introduction
Since ancient time, mankind has depended on plants
for  his  food,  shelter,  clothing  and  medicines.  The
science of Ayurveda allows us to become familiar with
plants  and  their  medicinal  properties.  The  genus
Barleria L.  belongs  to  the  family  Acanthaceae  and
there  are  many  reports  proving  the  medicinal
properties of this  genus.  A total  of 300 species have
been reported globally, mainly distributed throughout
the  Asia,  South  Africa  and  most  of  the  tropical
countries  (1).  Numerous  phytochemicals  reported
from various species of Barleria which are responsible
for medicinal properties  (2). The  Barleria species are
usually  seen  as  herbs  or  shrubs  with  simple  leaves
which are usually arranged in decussate manner and
few  species  have  sharp  apex.  They  have  diverse
coloured  tubular  flowers  with  epipetalous  stamens,
arranged  in  solitary,  axillary  and  cymes.
Thorns/spines are present at the axial positions, which
are  modified  bracts  (3).  In  ayurvedic  medicine,
Barleria species are used for their anti-fertility,  anti-
diabetic, cytoprotective, immunoprotective properties
(4). Especially, Iridoid glycosides which are present in
Barleria play  a  major  role  in  building  up  the
pharmacological  profile.  In  this  review,  we  have
discussed about the phytochemicals, pharmacological
activities  and  plant  tissue  culture  studies  of  some
important species of genus Barleria.
Phytochemistry of Barleria species
Macroscopic and microscopic studies on Barleria helps
us to understand the chemical compositions present in
the plant body right from leaves, stem and roots. There
are many pharmacologically active compounds present
in the plant body of B. prionitis. The decoctions of the B.
prionitis  leaves reveal the presence of metabolites like
alkaloids, tannins and oils. Tannins are also present in
the  bark of  B. prionitis  (5). Glycosides like scutellarein
7-rhamnosylglucoside,  is  reported  in  B.  prionitis  (6).
Acetyl Barlerin A with molecular formula C21H28O13 and
Barlerin B with molecular formula C19H26O12 are isolated
and  compared  with  the  standard  spectroscopic  data
and  they  are  found  to  be  iridoids  isolated  from  B.
prionitis  (7). Later,  Barlerin  is  also  reported  to  be
present in the methanolic extract of B. dinteri (8). From
the  ethanolic  extracts  of  B.  prionitis,  a  compound
known  as  Balarenone  was  isolated.  Spectral  studies
helped to  find  the  molecular  formula as C29H34O5  (9).
The gum fraction extracted from the ethanolic extract
of the B. prionitis showed the presence of Barlerinoside,
which  is  a  phenylethanoid  glycoside.  Spectral  data
revealed that the molecular formula of the compound
is C41H56O24  with chemical name β(3,4-dihydroxypheny-
l)ethyl-α-L-rhamnopyranosyl-(1′ 3 )-α-L-‴→ ‴
rhamnopyranosyl-(1 3′)-β-D-glucopyranosyl-(1″ 6′)-‴→ →
4-O-(3,4-dihydroxycinnamoyl)-β-D-glucopyranoside
(10).
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In  B.  lupulina the  aerial  parts  are subjected to
metabolite  analysis  using  ethanol  and  hexane.
During  chromatography  technique,  CH2Cl2-methanol
at  ratio  of  (80:20)  fractions  showed  presence  of
shanzhiside  methyl  ester  along  with  Barlerin  (8-O-
acetylshanzhiside  methyl  ester)  and Acetyl  Barlerin
(6,8-O,O-diacetylshanzhiside methyl ester) which are
chief iridoid glucosides present in  Barleria spp.  (11).
In  aerial  parts  of  B.  lupulina,  minor  iridoid
compounds  like  ipolamiidoside  and  6-O-
acetylshanzhiside methyl ester are isolated and they
are  characterised  using  spectroscopic  analysis  (12).
Compounds  like  6-O-p-methoxy-cis-cinnamoyl-8-O-
acetylshanzhiside  methyl  ester,6-O-p-methoxy-trans-
cinnamoyl-8-O-acetylshanzhiside methyl ester, 6-O-p-
cis-coumaroyl-8-O-acetylshanzhiside  methyl  ester
and  6-O-p-trans-coumaroyl-8-O-acetylshanzhiside
methyl ester are isolated from leaves of  B. lupulina
(13).  In  the  flowers  of  B.  lupulina  lupilinoside  is
isolated which is an iridoid diglucoside. Chemically it
is  8-O-  acetyl-2’-O-(β-gluco-pyranosyl)  mussaenoside
with  molecular  formula  C25H38O16  (14).  In  the
ethanolic extract of B. lupulina, iridoid glycosides like
8-O-  acetylipolamiidic  acid,  8-O-acetyl-6-O-(p-
methoxy-cis-cinnamoyl)shanzhiside and 8-O-acetyl-6-
O-(p-methoxy-trans-  cinnamoyl)shanzhiside  were
isolated  and  iridoid  rich  component  having  other
active  compound  showed  potent  alkaline
phosphatase activity (15). Spectral analysis conducted
on the aerial  extracts  from  B.  lupulina showed the
presence of chakyunglupulins A and B, which are the
4,8,8-trimethylcyclooct-  2-enone  derivatives.  The
molecular  formula  of  chakyuglupulin  A and B was
found to be C11H18O4 (16). In the aqueous extract of B.
lupulina, 4-ethylcatechol,  4-vinylcatechol  and  4-
methylcatechol  were  isolated  (17).  The  ethanolic
extracts  from  B.  lupulina  showed  the  presence  of
Barlupulins,  which  are  iridoid  glycosides.  NMR
spectroscopic observations reveal that  Barlupulin A
has  molecular  formula  C20H28O13,  Barlupulin  B  has
molecular formula with C22H30O14, and Barlupulin C, D
has  the  same  molecular  formula  C17H24O12  (18).
Another  iridoid  glycoside  namely  Barlupulin  C
methyl  ester  was  isolated  from  aerial  parts  of  B.
lupulina.  NMR  data  suggests  that  the  molecular
formula  of  the  compound  is  C18H26O12  (19).
Compounds like cyclobutane,1,1- dimethyl-2-octyl, 1-
Hentetracontanol,  1,2-Benzenedicarboxylic  acid,  di-
isooctyl  ester,  1-Hentetracontanol,  2-Hexyl-1-octanol
were isolated  from the  essential  oils  of  B.  lupulina
(20).
In  Barleria buxifolia  Linn., roots were subjected
to benzene extraction and it is seen that pigments like
Barleriaquinone. The molecular weight and chemical
formula of Barleriaquinone is found to be 238.0659
and  C15H10O3.  Spectroscopic  studies  help  us  to
understand  that  the  chemical  name of  the  isolated
quinone  is  1-hydroxy-7-methylanthroquinone  (21).
Spectroscopic  analysis  helps  us  to  find  out  that
different  compounds  are  present  in  B.  strigosa.
Striogoside is a compound isolated having a chemical
name 4-hydroxyphenylethyl 4-O-β-D-glucopyranosyl-
(1 3)-O-α-L-rhamnopyranoside  with  molecular→
formula C20H30O11 and another iridoid compound with
chemical name 10-O-trans-coumaroyl-eranthemoside
with  molecular  formula  C24H28O11  (22).  From  the
methanolic  extracts  of  B.  strigosa  parvifloroside  A
and  B  were  isolated,  which  are  phenylethanoid
glycosides. The molecular formula of parvifloroside A
and B is found to be C29H36O15, these compounds show
great anti-oxidant properties (23).
From the ethanolic extracts of Barleria trispinosa
an  iridoid  compound  is  isolated  with  molecular
formula  C25H38O16 having  chemical  name  6-α-L-
rhamnopyranosyl-8-O-acetylshanzihiside  methyl
ester,  which  is  illustrated  using  NMR  spectroscopy
(24).  In  Barleria  acanthoides there  are  diversified
compounds  isolated  from  the  n-butanol  extracts.
Spectral analysis suggests the presence of compounds
called Barleriside A and B. Molecular formula of the
isolated  compounds  are  C21H20O10  and  C29H35O15.
Chemical  name of  the  Barleriside  A is  found to  be
8,4′-dihydroxy-6-O-(β-D-glucopyranosyl)flavone  and
Barleriside  B  is  1-O-caffeoyl-6-(3′,4′-
dihydroxyphenyl)ethyl-O-α-L-rhamnopyranosyl-
(1 3)  β-d-glucopyranoside  (25).  In  the  n-butanolic→
subfraction of methanolic extract from B. acanthoides
showed  presence  of  neolignan  diglycoside  called
Barlericin.  High  resolution  fast-atom  bombardment
mass  spectroscopic  results  suggested  that  the
molecular  formula  of  the  isolated  Barlericin  is
C31H40O15  (26).  Mixture  of  4-hydroxy-trans-cinnamic
acid  alkyl  esters  and  oleanolic  acid  (triterpene
compound)  were  isolated  from  the  methanolic
extract of Barleria cristata (27). The list of important
phytochemicals present is represented in Table 1.
Analytical  methods  for  standardization  of
phytochemicals in Barleria species
Development of validated analytical methods is very
important  to  analyse  the  phytochemicals  in  the
polyherbal  extracts.  Chromatographic  techniques
were  employed  to  screen  the  biochemicals  in  the
plant extracts of Barleria. Important metabolites like
Barlerin, Acetylbarlerin and Shanzhisidemethylester
from  Barleria spp. were analysed using HPTLC. It is
seen  that  mobile  phase  having  chloroform-
ethylacetate- methanol-acetic acid at concentration of
3:3:3:1 showed best results at 233 nm. Upon statistical
data  analysis  it  was  seen  that  highest  content  of
barlerin  was  found  in  the  shoot  regions  of  B.
prionitis. Acetylbarlerin is found highest in the leaves
of  B. lupilina and Shanzhisidemethylester content is
found highest in leaves of B. prionitis (31). HPTLC and
RP-HPLC methods were developed for B. cristata. An
optimised HPTLC technique was developed with the
help  of  solvent  system  having  methanol:  ethyl
acetate:  toluene:  formic  acid  at  (1:  1:  7.5:  0.2)  to
separate  and  quantify  the  significant  anti-oxidants
like quercetin, apigenin and naringenin at 308 nm. In
RP-HPLC  method,  potassium  dihydrogen  phosphate
along  with  methanol  at  30:70  was  used  as  solvent
system and the detection of biochemicals was done at
330  nm.  These  standardised  analytical  methods
helped in evaluating the  phytochemical  markers in
plasma (32). Various saponins were identified in the
leaf  extracts  of  B.  cristata.  It  is  seen  that  in  the
optimised  mobile  phase  having  chloroform:  glacial
acetic  acid:  methanol:  water  at  6.4:3.2:1.2:0.8  ratio
was  used  for  analysis.  Anisaldehyde-sulphuric  acid
reagent is used to obtain the chromatogram and later
saponins were analysed from plates at 500 nm (33).
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In  B. prionitis,  HPTLC technique was developed
to quantify the various biochemicals. Saponins were
analysed  with  optimized  solvent  system  having
chloroform:  glacial  acetic  acid:  methanol:  water  at
ratio  of  6.4:3.2:1.2:0.8.  Chromatograms  were
compared with gallic acid, and it is seen that extracts
showed  presence  of  tannins.  Flavonoids  were
qualitatively  estimated  using  ethyl acetate:  formic
acid: glacial acetic acid: water at 10:1.1:1.1:2.6 ratio as
solvent system. It is seen that leaf showed the highest
percentage in the presence of saponins, tannins and
related metabolites when compared to roots (34). GC-
MS  analysis  was  employed  to  analyse  the
biomolecules  present  in  different  extracts  of  B.
buxifolia L. and B. montana. A total of 26 compounds
were analysed which comes under broader class of
flavonoids,  alkaloids,  terpenoids  and  tannins  from
ethanolic  extract  of  B.  montana.  It  is  seen  that
injector at 280 0C and helium gas with the flow at 0.8
ml/min is used in improved protocol (35). Similarly in
B.  buxifolia, 30  compounds  were  analysed  from
methanolic extract of leaf. It is seen that injector at
230 to 250 0C and helium gas with the flow at 1ml/min
was used in improved protocol (36).
Pharmacology of Barleria species
Anti-viral property
Cytopathic  effect  assay  is  conducted  against
respiratory syncytial virus (A2 strain) using 6-O-cis-p-
coumaroyl-8-O-acetylshanzhiside methyl ester and 6-
O-trans-p-coumaroyl-8-O-acetylshanzhiside  methyl
ester and it is found that 1:3 ratio of the cis and trans
isoforms  of  above  mentioned  compounds  isolated
from B. prionitis showed best half maximal inhibitory
concentration (IC50)  and half  best maximal effective
concentrations  (EC50)  at  42.2  µg/ml and  2.46  µg/ml
respectively (37). Plaque inhibition assay suggest that
the anti-viral  activity of  B. lupulina extracts  against
Herpes  simplex  virus  type  2  strain  G,  and  some
medical isolates of HSV-2 is very much promising and
its  activity  is  compared  with  Clinacanthus  nutans
which is also an Acanthaceae member. It is seen that
C.  nutans anti-viral  activity  is  not  up  to  the  mark
when compared to B. lupulina. Yield reduction assay
also suggests that  B. lupulina has promising viricidal
effects (38).
Anti-fertility activity
Methanolic  root extracts  of  B. prionitis reduced the
fertility in male rats. It is seen that administration of
100  mg/l concentration  of  the  plant  extracts
obstructed  the  spermatogenesis  in  rats.  Anatomical
studies  helped  to  understand  that  the  spermatids,
cross  sectional  area of  sertoli  cells  and leydig  cells
drastically reduced. Fertility tests conducted on male
rats proved the anti-fertility effect of B. prionitis (39,
40).  In  northern  Thailand  folk  medicine,  Barleria
species  are  used in  anti-fertility  and  when a  study
conducted on wistar male rats proved that B. strigosa
played  significant  role  in  inducing  hormonal
imbalance and ultimately reducing the sperm count
and making rats infertile (41). Different fractions of
crude methanol  extract  from  B.  prionitis root  were
eluted  with  3:1  and  1:1  concentrations  of
trichloromethane with methanol. The fertility ability
of the treated individuals decreased rapidly and the
parameters like sperm motility,  spermatogenic cells
count and biochemical parameters like total protein,
sialic  acid  and  glycogen  content  were  drastically
changed in treated rats. Fraction eluted with 1:1 ratio
of  trichloromethane  with  methanol  showed  best
results (42).
Anti-inflammatory activity
B. lupulina is used as anti-inflammatory agent and its
extracts are used as antidote for snake poision (43).
Methanolic  extracts  of  leaves  and  shoots  of  B.
lupulina showed  best  anti-inflammatory  activity
against  carrageenan  and  serotonin  induced  paw
oedema  and  the  extract  showed  results  which  are
equal  to  that  of  indomethacin,  which is  a standard
drug at 300 mg/kg concentration which is ideal (44).
Another  study  was carried  out  on different  animal
models  having  carrageenan  induced  paw  oedema
and  ethyl  phenylpropiolate  induced  ear  oedema.
Myeloperoxidase activity (for neutrophil  migration),
trypan  blue  exclusion  and  MTT  cytotoxicity  assays
demonstrates  that  methanolic  extracts  from  B.
lupulina showed  best  anti-inflammatory  activities
(45).  Alkyl  catechols,  which  are  present  in  hot
aqueous  extracts  of  B.  lupulina are  found  to  be
playing an important role in activating Nrf2 defence
pathway  which  ultimately  helps  the  organism  in
overcoming  the  inflammation  (17).  The
pharmacologically active components having iridoid
glucosides  in  the  aqueous  fraction  (TAF)  of  B.
prionitis showed  best  results  with  respect  to  anti-
inflammation. The study was carried on different sets
of rats which have induced the inflammation using
carrageenan,  histamine  and  dextran.  Treatment  of
these  effected  rats  with  TAF  fraction  showed
comparable  results  with  respect  to  standard  drugs
like Ibuprofen. Leucocyte migration inhibition assay
also suggested that TAF fraction of  B. prionitis taken
from  methanol  extract  showed  best  results  (46).
Membrane  stabilization  activity  and  mast  cell
protection activity is studied after the administration
of hydro alcoholic extracts of B. prionitis in rats. It is
seen that ethanolic extract at 10 µg/ml concentration
showed  best  results  with  respect  to  membrane
stabilization  and  it  is  comparable  to  that  of
indomethacin,  standard  drug  at  10  µg/ml
concentration.  The  percentage  of  degranulation  of
mast cells is monitored and it is seen that 10 µg/ml
concentration  showed  best  results  against  the
toxicant compound 48/80 (47). Carrageenan induced
paw oedema model  is  established and effect  of  the
anti-inflammatory  activity  of  methanolic  extract
from  B.  prionitis is  estimated.  It  is  seen  that
methanolic  extract  at  500  mg/kg  concentration
showed best efficiency in reducing the inflammation
(48). 8-O-acetyl shanzhiside methyl ester, shanzhiside
methyl  ester  rich  component  from  B.  prionitis
showed  inhibition  against  myeloperoxidase,  matrix
metalloproteinase-9  and  elastase  enzymes  and
release  of  cytokines  which  prove  the  anti-
inflammatory activity (49). 
The  effect  of  B.  cristata leaf  extracts  on
carrageenan  induced  paw  oedema,  acetic  acid
induced vascular permeability and castor oil induced
diarrhoea was studied and it was seen that 500 mg/kg
concentration of  the  extract  showed best  results  in
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inhibiting  the  oedema,  inhibited  the  vascular
permeability.  Indomethacin  is  used  as  a  standard
drug  at  10  mg/kg  in  all  studies  (50).  Leaves  of  B.
cuspidate  are  studied  for  their  wound  healing
property. The methanolic  fractions at 10% w/w and
15%w/w concentrations  were used for the study.  It
was  seen  that  these  fractions  showed  best  results
with respect to wound healing (i.e.,  decrease in the
wound  length)  and  comparable  to  that  of  the
nitrofurazone  which  is  the  standard  drug  (51).
Formalin  at  the  concentration  of  0.1  mg/kg  is
administered to the albino Wistar rats to induce the
inflammation.  It  is  seen  that  leaf  ethanol  extracts
from  B.  montana  at  300  mg/kg  body  weight
concentration reduced the inflammation. The blood
biochemistry parameters like levels of haemoglobin,
red  and  white  blood  cells  were  also  taken  into
consideration  and  the  efficiency  is  compared  with
indomethacin at 25 mg/kg body weight concentration
(52).
Neuroprotectivity activity
Methanolic  extracts  of  B.  lupulina are  studied  for
their  neuro-pharmacological activity in mice, which
are induced by propylene glycol. General behaviour
tests  for sound response, touch and pain responses
are  conducted  on  different  sets  of  mice  and  rats.
Along with these muscle relaxant tests like traction
test, rotarod performance tests, 30o inclined tests are
conducted.  It  is  seen  that  in  all  the  above  tests
conducted,  on  overall  B.  lupulina  extracts  show
promising pharmacological activity when compared
to standard neuroleptics (53).
Anti-oxidant activity
DPPH  radial  scavenging  activity  suggest  that  the
availability of the anti-oxidant molecules are present
in the methanolic extracts of whole  B. prionitis and
from the leaf extracts  of  B. greenii,  as they showed
ideal  half  maximal  effective  concentration.  The
efficiency  is  compared  with  that  of  ascorbic  acid
which is a strong anti-oxidant (54). The antioxidant
property  of  the  ethanolic  extracts  from  B.  prionitis
helped  in  reversing  the  cataract  which  is  induced
with the help of galactose and selenite at 25 moles/kg
body weight concentration. Ethanolic extract at 200
mg/kg  and  400  mg/kg  body  weight  concentration
showed best results in reducing the oxidative stress
(55).  Ferric  thiocyanate  method  and  thiobarbyturic
acid methods also suggest that the ethanolic extract
from B. prionitis have promising anti-oxidant activity
(56).  Ferrous  reducing  power,  DPPH  radial
scavenging  activity,  nitric  oxide  radical  scavenging
activity,  hydrogen  peroxide  radical  scavenging
activity,  superoxide  anion  scavenging  activity  and
ABTS+ radical  cation  decolourisation  assay  were
conducted on leaf and root extracts of  B. noctiflora
and root extracts showed best results and performed
best anti-oxidant activity (57). The ethanolic extracts
from  B. cristata were checked for their anti-oxidant
activity.  DPPH  assay,  ABTS+ assay  and  FRAP  assay
were  conducted  to  check  the  efficiency  of  the
ethanolic  extracts.  It  is  seen that  ethanolic  extracts
showed best results in all conducted assays and it is
compared  with  that  of  butylated  hydroxyl  toluene
(BHT)  which  is  a  standard  anti-oxidant  (58).  DPPH
radical  scavenging  assay,  nitric  oxide  radical
scavenging  assay  was  conducted  on  ethanolic
extracts  of  B.  gibsonii.  The  results  suggest  that  the
presence  of  pharmacologically  significant  anti-
oxidant molecules which showed their  efficiency in
scavenging the DPPH radicals  which was compared
with  standard  anti-oxidant  molecule,  ascorbic  acid.
And scavenging of nitric oxide radicals from sodium
nitroprusside  were  also  seen  which  ultimately
proved their promising anti-oxidant activity (59).
Immuno-protective activity
Immuno-protectivity of the methanolic extracts from
B. lupulina was proved with the help of checking the
parameters  like  WBC  count,  spleen  WBC  count,
spleen  weight  and  delayed  type  hypersensitivity
reaction on footpad thickness. It is seen that 600 mg/
kg concentration of the extract showed good results
along with 300 mg/kg (60). Oral administration of the
iridoid  fraction  of  the  methanolic  extract  from  B.
prionitis triggered the immune response in the rats.
Different  tests  like  neutrophil  adhesion  test,
haemagluttinating  antibody  titre  test,  delayed  type
hypersensitivity  response  test,  cyclophosphamide-
induced  immunosuppression  test  and  macrophage
phagocytosis  by  carbon  clearance  test  were
conducted to check the efficiency of the extracts. It is
proved  that  shanzhiside  methyl  ester  and  barlerin
rich iridoid component helps in immunomodulation
(61). 
Anti-cancer activity
The  cytotoxicity  effect  of  the  Barleria quinones
(Barleriaquinone-I, Barleriaquinone-II) isolated from
B.  buxifolia roots  are  studied  and  it  is  seen  that
Barleriaquinone-II showed best LD50  when compared
to  Barleriaquinone-I  in  human  breast
adenocarcinoma  cells  (MCF7)  (62).  The  anti-cancer
activity of the methanolic extracts from B. grandifolia
were  studied  against  cancer  cell  lines  i.e.,  A-  549
(human  lung  cancer)  cells,  Dalton’s  lymphoma
ascites.  Methanolic  extracts  showed  best  half-
maximal  inhibitory  concentration  against  dalton’s
lymphoma ascites with the value 137.2 µg/ml. Various
parameters  like  tumor  weight,  viable  cell  count,
tumor volume were taken into consideration and the
methanolic extracts showed best anti-tumour activity
(63).
Anti-arthritic activity
B. lupulina from the ancient days is used for treating
arthritis.  Scientifically  it  is  proved  that  methanolic
extracts  from the  leaves  showed promising activity
against arthritis.  Study was carried out on different
animal  models  of  induced  arthritis  like  formalin-
induced  arthritis,  collagen  type  II-induced  arthritis,
monosodium iodoacetate induced osteoarthritis. It is
seen that at 300 mg/kg and 600 mg/kg concentrations
of  the  administered  extracts  showed  comparable
promising  anti-arthritic  activity  with  that  of
indomethacin  at  10  mg/kg  concentration  (60).
Artificially  arthritis  is  induced using chemicals  like
formaldehyde  and  freund’s  adjuvant  (FCA)  in  the
sprague-dawley rats. It is seen that ethanolic extracts
of B. prionitis leaves showed decreased arthritis score
and paw volume which was increased as a  sign of
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arthritis.  Ethanolic extract of concentration 250 mg/
kg  showed  best  results  with  respect  to  all  tests
conducted. The efficiency of anti-arthritic activity is
checked with the standard drug, diclofenac at 4 mg/
kg body weight concentration (64). 
Anti-Ulcer activity
Aerial  parts  (Leaves,  shoot  regions)  of  B.  lupulina
were  subjected  to  methanolic  extraction  and  their
anti-ulcer  properties  are  studied.  It  is  seen that  in
pylorus  ligated  rats  the  methanolic  extract  of  B.
lupulina at  200  mg/kg  concentration  showed
promising  anti-ulcer  activity  and  the  results  are
comparable with famotidine at 30 mg/kg which is the
standard  anti-ulcer  drug.  The  effect  of  B.  lupulina
extracts  on different  animal  models  where ulcer  is
induced using stress, alcohol and Indomethacin. It is
seen that methanolic  extracts of  B. lupulina showed
best  results  in  alcohol  induced  stress  even  when
compared  with  famotidine  and  omeprazole  (65).
Aspirin  at  200  mg/kg  concentration,  ethanol  at  1
ml/200 mg concentration with respect to body weight
is  administered  to  induce  ulcer  in  rats.  Iridoid
fraction from  B. prionitis  at 200 mg/kg body weight
concentration showed best efficiency in reducing the
ulcers.  Cold-restraint  stress  and  pylorus  ligated
induced ulcer  models  were also  developed and the
activity  of  the  iridoid  fraction  on them is  checked.
Many  parameters  like  acid  output,  pH  value  and
gastric juice amount were taken into consideration. It
is concluded that  B. prionitis extracts which are rich
in iridoid fraction have promising anti-ulcer activity
(66). In pylorus ligated induced ulcer, the efficiency
of ethanolic extracts from B. gibsoni was checked for
its  anti-ulcer  property.  It  is  seen that  acidity  levels
and  ulcer  lesions  got  reduced  upon  the
administration  of  500  mg/ml  concentration  of  the
extracts  and  its  capacity  to  reduce  ulcer  lesions  is
compared  with  omeprazole  at  20  mg/ml
concentration.
Anti-diabetic activity
In the streptozotocin induced diabetic  rats the anti-
diabetic  activity  of  the  methanolic  extracts  of  B.
lupulina is studied and it was found that at 300 mg/kg
body  weight  concentration  showed  decreased
amount of glucose content in the blood and showed
comparing efficiency with Glibenclamide at 10 mg/kg
body  weight  concentration  (67).  In  another  study,
animals were induced with alloxan monohydrate at
150 mg/kg concentration and ethanolic extracts of B.
prionitis were administered. It is seen that ethanolic
leaf extracts showed potent anti-diabetic activity and
showed the reduced glucose levels by increasing the
serum insulin levels when compared to root extracts
(68). Ethyl acetate fraction from the ethanolic extract
of B. noctiflora showed promising in-vitro and in-vivo
anti-diabetic activity. The anti-diabetic property was
compared with glibenclamide at 10 mg/kg. The ethyl
acetate fraction showed reduced glucose levels in the
blood which was isolated from high fat diet fed and
streptozotocin induced diabetic rats at 40 mg/kg body
weight  concentration  (69).  The  ability  of  inhibiting
the  α-amylase  and  α-glucosidase  enzymes  by
ethanolic and petroleum ether extracts of  B. cristata
leaves proved its anti-diabetic activity. It is seen that
100  µl  concentration  of  both  extracts  showed
promising efficiency (70). 
Hepatoprotectivity
In  B.  prionitis its  iridoid  rich  fraction  was  used  to
study the hepatoprotectivity. The study is carried out
on different rat models which are liver toxicated with
drugs  like  carbon  tetrachloride  (100  µl/kg),
galactosamine (300 mg/kg) and paracetamol (200 mg/
kg).  The  median  lethal  dose  of  the  drug  in  oral
administration and intraperitoneal administration is
studied.  Serum  parameters  (alkaline  phosphatase,
alanine transaminase, aspartate transaminease) and
hepatic  parameters  (lipid  peroxidation)  are  taken
into consideration for the study and this rich fraction
of  B.  prionitis is  proved to  have  hepatoprotectivity
(71).  The  methanolic  extracts  of  B.  montana leaves
were administered in the liver damaged rats and the
serum enzyme parameters were analysed. It is seen
that methanolic extracts at 500 mg/kg concentration
successfully  inhibited  the  enzyme  levels  of  serum
glutamic oxaloacetic transaminase (SGOT) and serum
glutamic  pyruvic  transaminase  (SGPT)  and  the
efficiency  is  compared  with  silymarin  which  is
standard  drug  against  liver  disorders.  Anatomical
studies at tissue level also suggested that B. montana
has capacity to repair the damaged liver tissues (72).
Another  study  was  carried  out  on  liver  damaged
animal  model  which  is  caused  with  the  help  of
carbon  tetrachloride.  It  is  seen  that  methanolic
extracts  from the aerial  parts  of  B.  montana at  the
concentration of 400 mg/kg and 800 mg/kg reduced
the  serum  sensitive  enzymes  levels  for  the  liver
damage  i.e.,  serum  glutamic  oxaloacetic
transaminase, serum glutamic pyruvic transaminase,
alkaline phosphatase (73).
Anti-bacterial property
Compounds  like  Balarenone,  pataline,  13,14-seco-
stigmasta-5,14-diene-3-α-ol which were isolated from
the crude extract of B. prionitis showed anti-bacterial
property  especially  against  Bacillus  cereus (ATCC
14579)  and  Pseudomonas  aeruginosa (ATCC  27853)
(9).  Different  types  of  plant  extracts  using  soxhlet
apparatus were developed from the dried leaves of B.
prionitis; among them ethanolic extract at 10 mg/ml
showed  best  anti-bacterial  activity  against
Staphylococcus aureus  followed by  Salmonella typhi,
Vibrio  cholera,  Escherichia  coli  (74). Different
fractional  extracts  made  out  of  hexane  and  ethyl
acetate  from  B.  prionitis showed  anti-bacterial
activity (75). Different solvent extracts like methanol,
ethanol,  chloroform, di-chloromethane,  acetone and
water of  B.  montana  Nees are studied for their anti-
bacterial property. Anti-bacterial study is carried out
on  species  like  Bacillus  subtilis,  Streptococcus
pneumoniae, Staphylococcus aureus,  Escherichia coli,
Salmonella typhi,  Pseudomonas aeruginosa,  Klebsiella
pneumoniae and  Proteus  vulgaris.  It  is  seen  that
acetone extracts showed best anti-bacterial property
in  the  decreasing  order  against  Pseudomonas
aeruginosa, Escherichia coli and Salmonella typhi. The
efficiency  is  compared  with  the  standard  drug
streptomycin  (76).  The efficiency of  the  methanolic
extracts of  B. montana at 100 mg/ml and 200 mg/ml
concentration  were  tried  on  different  species  of
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gram-positive bacteria like Bacillus subtilis, B. cereus,
B. pumilis,  Staphylococcus aureus and gram-negative
bacteria  like  Escherichia  coli,  Psuedomonas
aeuriginosa,  P.  vulgaris,  Serratia  marceseans.  It  is
seen  that  the  efficiency  was  moderate  and  that  is
compared with 10 µg/ml chloramphenicol,  which is
the  standard  drug  (73).  The  essential  oil  extracted
from  B.  lupulina having  many  important
phytochemicals like cyclobutane,1,1-dimethyl-2-octyl,
1-Hentetracontanol,  1,2-Benzenedicarboxylic  acid,
diisooctyl  ester,   2-Hexyl-1-octanol  showed its  anti-
bacterial  affect  against  the  species  like  Bacillus
pumilus and Staphylococcus aureus (20).
Anti-fungal activity
Minimum  inhibitory  concentration  and  minimum
fungicidal  concentrations  of  the  extracts  of
petroleum  ether,  dichloromethane  from  B.
albostellata  showed  best  results  against  Candida
albicans (ATCC  10231).  In  the  same  way  the
ethanolic  extracts  of  B.  greenii leaves  showed
highest minimum inhibitory dilution and proved its
fungicidal  activity  and that  efficiency is  similar  to
that of its root and stem which ultimately helps the
harvesters  to  go  with  plant  part  substitution  to
replace  the  less  available  parts  (54).  Methanolic
extract of B. montana at concentration of 100 mg/ml
and 200 mg/ml showed moderate anti-fungal activity
against  fungal  species  like  Aspergillus  niger,
Rhizopus  stolonifer,  Sacharomyces  cerevisiae and
Pencillium chrysogenum. The efficiency is compared
with  that  of  10  µg/ml  nystatin  (73).  Hot  water
extracts  from  the  aerial  parts  of  B.  grandiflora
showed  promising  antifungal  activity  against  A.
fumigatus.  It  is  seen  that  the  extracts  down
regulated  the  metabolic  pathways  which  are  very
much important for the survival and pathogenicity
of the A. fumigatus (77). Natural dye extracted from
aerial  parts  of  B.  prionitis showed  anti-fungal
activity  against  species  like  A.  flavus,  A.  niger,  A.
parasiticus,  Fusarium  moniliforme and  Penicillium
canescens.  The  minimum  inhibitory  concentration
of  the  natural  dye  against  the  mentioned  fungal
species ranges like 23.25, 22.75, 23.5, 22.5 and 23 µg/
ml. The fabrics which are made out of this natural
dye is recommended for textile purposes (78).
Anti-diarrhoeal activity
Iridoid  glycoside  component  isolated  from  B.
prionitis was studied for its anti-diarrhoeal activity.
Different  tests  like  PGE2-induced  enteropooling,
charcoal  transit  test  was  conducted  and  it  is  seen
that  iridoid  component  successfully  inhibited  the
enteropooling  and  fluid  transition.  100  mg/kg
concentration of the extract inhibited the castor oil
induced  diarrhoea  and  the  efficiency  is  compared
with loperamide, which is a standard drug (79).
Anti-hypersensitive activity
Methanolic  extract  of  the  leaves  of  B.  prionitis  is
employed  for  studying  the  anti-hypersensitive
activity. Hypersensitivity is induced in the rat with
the help of  Deoxycoticosterone acetate  (DOCA) salt
at the concentration of 20 mg/kg body weight. It was
observed  that  methanolic  extract  at  400  mg/kg
showed best results in reducing hypertension (80). 
Marketed medicinal formulations from Barleria
spp.
Barleria species  are  used  in  formulation  of  herbal
toothpastes.  Vicco  vajradanti  (81)  is  a  herbal
toothpaste  made  from  B.  prionitis,  which  have
capacity to reduce the salivary glucose and pH. It is
also seen as a chief ingredient in Patanjali Dantkanti
(82).  B.  prionitis is  the  chief  component  in
Sahacharadikashayam,  an  ayurvedic  polyherbal
formulation  which  is  used  as  an  anti-oxidant  (83).
Whole plant is of B. prionitis is used in the polyherbal
formulation  of  Maharasnadikwath.  This  liquid
extract  showed  great  anti-arthritic  potential  with
anti-oxidant activity (84).
Tissue culture Studies in Barleria spp.
Biotechnological  approach  helped  the  mankind  to
solve  his  problems  in  effective  manner.  Tissue
culture  is  one  of  such  biotechnological  tool which
helped to conserve the medicinal  plant  species and
their  medicinally  important  metabolites.  Barleria
species  being  threatened  in  the  wild,  there  is  an
immense  requirement  for  the  tissue  culture
technique for filling the gap in the demand for the
cell  lines  and  the  raw  materials.  The  information
regarding the in-vitro development of Barleria is very
much limited. 
It is seen that when nodal explants of B. prionitis
cultured  in  the  nutrient  medium  having  0.4  ppm
thidiazuron (TDZ)  along  with 1.5 ppm BAP showed
best results  in inducing the shoot development and
the subculturing multiplication media having 5 ppm
6-benzylaminopurine  (BAP)  along  with  2  ppm  α-
naphthaleneacetic  acid  (NAA)  showed  good
proliferation  capacity  (85).  Another  study  also
revealed that nodal explants were grown on the MS
media supplemented with 1.5 ppm BAP with 0.4 ppm
TDZ showed highest  number of  shoots  and highest
mean  shoot  length  (86).  Nodal  explants  having
axillary  buds  were  used  as  explants  for  the  shoot
induction and bud break in B. prionitis. It is seen that
MS  media  supplemented  with  BAP  at  8.88  µM
concentration showed best results. It is seen that BAP
at 4.44 µM concentration showed best multiplication
efficiency (87). BAP at 1.5 ppm along with NAA at 1
ppm  concentration  showed  best  response  in  the
development of shoot from the shoot tip explant in B.
prionitis (88).  MS media  supplemented  with  1  ppm
BAP  and  0.5  ppm  TDZ  showed  best  results  with
respect to the development of shoots from the nodal
explants of B. prionitis (89).
Development of  callus  is  important  task and it
helps in the  establishment of cell cultures. Callus was
developed  from  different  explants  of  B.  prionitis.
0.0125 ppm of 2,4-D along with Kinetin (KN) showed
good  results  in  development  of  callus  from  leaf
explant  and  at  0.025  ppm  of  2,4-D  along  with  KN
showed good results  in development of callus from
shoot explants (90). MS medium supplemented with 2
ppm of IAA along with BAP showed best results with
respect to the leaf explants of  B. lupulina  Lindl. and
developed callus was also screened for their potential
medicinal properties (91). Callus was developed from
the  leaf  explants  which  were  cultured  on  the  MS
medium having 2 ppm of IAA along with 1.5 ppm of
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BAP (92). Compact green callus was developed from
the leaf explants of  B. lupulina  Lindl. It is seen that
MS media having 0.1 ppm NAA along with 0.5 ppm
BAP showed best response (93).
In  B.  prionitis rooting  efficiency  was  checked
under  the  influence  of  different  auxin
concentrations. It is seen that Indole butyric acid at
0.4  ppm  concentration  showed  best  root  inducing
capacity  of  the  in-vitro grown  shoots  (86).  Half
strength  MS  media  supplemented  with  2.46  µm
Indole  butyric  acid  (IBA)  showed good response in
rooting with good mean number and the length (87).
0.5 ppm of IBA supplemented in the half strength MS
media showed best results  in development of  roots
from the  in-vitro grown micro shoots of  B. prionitis
(89).
Conclusion
Biotechnological studies reveal that  Barleria L.  have
potential drugs which help in treating chronic illness.
Scientifically there are many reports which support
its requirement in curing many diseases which are
chronic in nature. The phytochemicals present helps
to  overcome  different  health  issues  like
inflammation, microbial infections, diabetes, hepatic
tissue  related  issues,  cancer,  arthritis,  immune
deficiency  etc..  Most  importantly  the  metabolites
from  Barleria are used in creating the organism in-
fertile.  So,  consuming  the  crude  extracts  without
proper dose and doctor concern may lead to cause
different fertility related issues. So, with the present
scientific  evidence  it  is  the  responsibility  of  the
scientific  community to explore further medicinally
important metabolites and use them for the benefit of
the humankind.
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